Compare Mechanisms, Doses & UK Pricing Side-By-Side
Mounjaro V Wegovy Doses: Core Mechanism Differences
The fundamental difference between Mounjaro v Wegovy doses lies in their active mechanisms—Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. Mounjaro uses tirzepatide, which acts on both GIP and GLP-1 receptors simultaneously, creating a dual-agonist approach to appetite regulation. This dual mechanism means Mounjaro may work through slightly different pathways compared to Wegovy's single-target approach. Both prescription-only medicines require weekly injections but follow distinct dosing schedules that cannot be interchanged.
Wegovy follows a structured 5-dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. Mounjaro uses a different 6-dose progression starting at 2.5mg and escalating through 5mg, 7.5mg, 10mg, 12.5mg, up to 15mg maximum. The numerical values aren't directly comparable due to different molecular structures—2.4mg Wegovy doesn't equal 2.5mg Mounjaro in terms of clinical effect. Understanding these Mounjaro v Wegovy doses differences helps explain why switching between treatments requires clinical supervision. Both medications are available through EverydayMeds' GPhC #9012878 registered pharmacy with appropriate prescriber oversight.
UK Pricing Analysis: Mounjaro V Wegovy Doses Cost Comparison
When comparing Mounjaro v Wegovy doses pricing, Wegovy starts at £79.99 for the initial 0.25mg dose (with FIRST40 discount code for new customers), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Mounjaro pricing follows its own structure with different cost points across the 2.5mg to 15mg range. The Intro Duo bundle (0.25mg & 0.5mg Wegovy) costs £169.99, providing convenient two-month starter supply. Returning customers benefit from the DOSE25 discount code applied at checkout, with all prices representing the final amount after discount application.
EverydayMeds offers comprehensive bundle options for sustained treatment—the Ultimate Stability Trio provides three months of 2.4mg Wegovy maintenance doses for £649.99, ensuring consistent supply without multiple orders. The Progress Trio (0.5mg, 1mg & 1.7mg) costs £369.99, covering months 2-4 of dose escalation seamlessly. Bundle pricing prioritises convenience rather than pure cost savings—fewer orders mean Reliable Supply continuity and simplified delivery scheduling. When evaluating Mounjaro v Wegovy doses costs, consider both the immediate price and long-term treatment commitment, as both medications require ongoing use for sustained weight management benefits.
Clinical Evidence: Wegovy STEP Trials Overview
Wegovy's clinical profile comes from the comprehensive STEP trial programme, with STEP 1 demonstrating average clinically studied weight loss at 68 weeks when used alongside diet and exercise (compared to 2.4% with placebo). The SELECT cardiovascular outcomes trial showed 20% reduction in major cardiovascular events, providing additional health benefits beyond weight management. These Mounjaro v Wegovy doses comparisons must acknowledge different trial designs and patient populations, making direct percentage comparisons inappropriate.
STEP 2 specifically studied patients with type 2 diabetes, showing 9.6% average weight loss, whilst STEP 3 combined Wegovy with intensive behavioural therapy achieving 16% average reduction. Long-term STEP 5 data maintained clinically studied weight loss at two years, demonstrating sustained efficacy when treatment continues. All clinical evidence uses conditional language—patients "may experience" weight loss rather than assured outcomes, as individual responses vary significantly across the treatment population.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the incretin hormone your intestines naturally release after eating to signal fullness to your brain. This mechanism reduces appetite by acting on hypothalamic appetite centres, promoting satiety after smaller meals and potentially reducing food cravings between eating occasions. The once-weekly injection maintains consistent blood levels, providing sustained appetite regulation compared to natural GLP-1 which degrades rapidly. Unlike medications that work through fat absorption blocking or stimulant effects, Wegovy works with your body's existing appetite signalling pathways. Understanding this mechanism helps explain why Mounjaro v Wegovy doses produce different clinical profiles—Mounjaro's dual GIP+GLP-1 action creates additional metabolic effects beyond pure appetite suppression. The FlexTouch pen device delivers precise doses subcutaneously, typically into the thigh, abdomen, or upper arm rotation sites.
EverydayMeds Ordering Process: Assessment to Delivery
Obtaining either treatment through EverydayMeds begins with our 3-minute online clinical assessment, covering medical history, current medications, previous weight management attempts, and treatment goals relevant to your Mounjaro v Wegovy doses decision. Our UK-based prescribers review applications within 3 working days (express 24-hour service available), ensuring clinical appropriateness before approving either medication. Once approved, both Wegovy and Mounjaro ship via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity throughout transport. The streamlined process eliminates traditional pharmacy visits whilst maintaining full clinical oversight and safety standards. All prescriptions comply with MHRA regulations and NICE guidance, with ongoing monitoring available through your treatment journey. EverydayMeds operates as a fully GPhC-registered pharmacy (#9012878), providing legitimate prescription-only medicine access with appropriate clinical governance.
Storage & Practical Considerations: Mounjaro V Wegovy Doses
Storage represents a key practical difference when comparing Mounjaro v Wegovy doses—Wegovy maintains potency for 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require 2-8°C refrigerated storage before first use, but Wegovy's extended temperature tolerance provides superior travel flexibility and reduces waste from accidental temperature exposure. The FlexTouch pen system used by Wegovy offers intuitive dose selection with audible clicks and clear dose windows, whilst Mounjaro uses its own pen device with different handling characteristics. Weekly injection timing should remain consistent—same day each week—regardless of which treatment you choose. Both medications require gradual dose escalation over several months, with dose escalation schedules that cannot be accelerated without clinical supervision. Neither treatment should be frozen, shaken vigorously, or exposed to direct sunlight during storage.
Treatment Duration & Maintenance: Long-Term Mounjaro V Wegovy Doses Planning
Both Mounjaro and Wegovy require long-term commitment for sustained weight management benefits—STEP 1 extension data shows patients regained approximately two-thirds of lost weight within one year of stopping Wegovy treatment. This pattern emphasises that weight management represents an ongoing medical condition rather than a short-term intervention, making treatment choice particularly important for long-term planning. The maintenance phase differs significantly between treatments—Wegovy typically maintains 2.4mg weekly (with 7.2mg higher dose recently approved by MHRA), whilst Mounjaro maintenance doses range from 5mg to 15mg depending on individual response and tolerance.
When planning extended treatment with either option, consider factors beyond initial weight loss—tolerability profile, injection experience, storage requirements, and cost sustainability all influence long-term success. EverydayMeds supports both treatment pathways with consistent supply reliability, clinical monitoring, and transparent pricing across all dose levels. The Mounjaro v Wegovy doses decision should incorporate your lifestyle factors, travel patterns, storage capabilities, and financial planning for sustained treatment commitment. Both treatments work best as part of comprehensive lifestyle changes including dietary modifications and increased physical activity, rather than standalone pharmaceutical interventions.
Choose Your Treatment: Both Available From EverydayMeds
EverydayMeds provides access to both Wegovy and Mounjaro through our comprehensive weight management service, allowing your prescriber to recommend the most appropriate option based on your individual clinical profile and preferences. New customers apply discount code FIRST40 at checkout, whilst returning patients use DOSE25 for ongoing treatment supply. Our clinical team supports both treatment pathways with the same high standards of care, cold-chain delivery, and ongoing monitoring throughout your weight management journey. The decision between Mounjaro v Wegovy doses ultimately depends on factors including your medical history, treatment goals, lifestyle requirements, and prescriber recommendation rather than simple cost comparison. Both represent clinically proven approaches to weight management when used as prescribed alongside appropriate diet and exercise modifications. Start your clinical assessment today through https://everydaymeds.co.uk/collections/weight-loss to determine which treatment option suits your needs best.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
